RSCI (Redwood Scientific Technologies) Tariff Resilience Score: 0/10 (As of Jul. 10, 2026)


What is Redwood Scientific Technologies Tariff Resilience Score?

Redwood Scientific Technologies has the Tariff Resilience Score of 0, which implies that the company might have .

Redwood Scientific Technologies has Redwood Scientific's reliance on international suppliers for raw materials and manufacturing exposes it to tariff risks. The company has limited ability to pass costs to consumers, making it vulnerable to trade policy changes.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Redwood Scientific Technologies might have .

Redwood Scientific Technologies  (OTCPK:RSCI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Redwood Scientific Technologies Tariff Resilience Score Related Terms

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.